Antibodies attack immune proteins
Autoimmune polyendocrine syndrome, or APS-I, afflicts one in 100,000 people and is characterized by disrupted thyroid and adrenal gland function and recurrent skin infections with one type of yeast. Normally, the immune system produces cytokines that help protect the body against airborne yeast and other environmental pathogens.
Two teams of researchers—one led by Anthony Meager at the National Institute for Biological Standards and Control (UK), and the other led by Desa Lilic at Newcastle University (UK) and Jean-Laurent Casanova at Rockefeller University (New York)—found that patients with APS-I produce autoantibodies that bind to and disarm these yeast-fighting cytokines.
It is not yet clear why these patients are prone to infection with only one type of yeast. But these studies suggest that cytokine replacement therapy might be considered in the treatment of APS-I patients.
About The Journal of Experimental Medicine
The Journal of Experimental Medicine (JEM) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JEM content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit www.jem.org.
Kisand, K., et al. 2010. J. Exp. Med. doi:10.1084/jem.20091669.
Puel, A., et al. 2010. J. Exp. Med. doi:10.1084/jem.20091983
Media Contact
All latest news from the category: Studies and Analyses
innovations-report maintains a wealth of in-depth studies and analyses from a variety of subject areas including business and finance, medicine and pharmacology, ecology and the environment, energy, communications and media, transportation, work, family and leisure.
Newest articles
Scientists transform blood into regenerative materials
… paving the way for personalized, blood-based, 3D-printed implants. Scientists have created a new ‘biocooperative’ material based on blood, which has shown to successfully repair bones, paving the way for…
A new experimental infection model in flies
…offers a fast and cost-effective way to test drugs. Researchers at the Germans Trias i Pujol Research Institute and Hospital have reinforced their leading role in infectious disease research by…
Material developed with novel stretching properties
KIT researchers produce metamaterial with different extension and compression properties than conventional materials. With this material, the working group headed by Professor Martin Wegener at KIT’s Institute of Applied Physics…